Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials Academic Article uri icon

Overview

MeSH Major

  • Clinical Trials as Topic
  • Disease Progression
  • Idiopathic Pulmonary Fibrosis
  • Outcome Assessment (Health Care)
  • Piperazines
  • Sulfones

abstract

  • Our findings suggest that endostatin treatment inhibits the increased MVD, inflammation and alveolar epithelial cell apoptosis, consequently ameliorating BLM-induced pulmonary fibrosis in rats.

authors

publication date

  • July 13, 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3729659

Digital Object Identifier (DOI)

  • 10.1186/1465-9921-14-73

PubMed ID

  • 23848435

Additional Document Info

start page

  • 56

volume

  • 14

number

  • 1